Total Valuation
BioNeutra Global has a market cap or net worth of C$1.39M. The enterprise value is C$6.91M.
Market CapC$1.39M
Enterprise ValueC$6.91M
Share Statistics
BioNeutra Global has 46,448,788 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,448,788
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioNeutra Global’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of BioNeutra Global is ―. BioNeutra Global’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, BioNeutra Global had revenue of ― and earned -2.11M in profits. Earnings per share was ―.
Revenue―
Gross Profit4.14M
Operating Income-1.48M
Pretax Income―
Net Income-2.11M
EBITDA-351.91K
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
BioNeutra Global pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change0.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
BioNeutra Global upcoming earnings date is Aug 27, 2025, TBA (Confirmed).
Last Earnings DateMay 23, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
BioNeutra Global as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, BioNeutra Global has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
BioNeutra Global EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
BioNeutra Global has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for BioNeutra Global is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―